Healthy Trac™ Market For Digestive Health #2 Retail Product Category ($2 Billion). 60 Million Suffer Digestive Health Problems Each Year. #1 Reason For Emergency Room Visits; Responsible For 36 Million Visits a Year.

Attributes As A Functional Food And Beverage Ingredient Clinically Safe Results With Humans. Low Calorie, Fat, Sodium And No Cholesterol. Excellent Source of Fermentable Dietary Fiber. Low Protein And Thermostable. Low Viscosity, High pH And Salt Compatible. Low Sensory Impact.

Health Benefits of Healthy Trac™ Promotes a Healthy Environment For Long Term Colon Health. A Gentle Laxative For Consistent Regularity. Does Not Promote Laxative Dependence. A Weapon to Help Fight Cholesterol. Helps Reduce Insulin, Carbohydrate And Blood Sugar Levels. An Important Benefit For Diabetics. Enhances The Immune System by Increasing Natural Killer Cell Activity And Cellular Immune Response.

Healthy Trac™ Safety Profile Common Name: Larch Sugar. Chemical Name: Arabinogalactan. FDA Approved As A Direct Food Additive. FEMA GRAS Listed. DSHEA Approved (Met Pre-1994 Market Requirement). Structure/Function Filed FDA 1998 GRAS Self-Affirmed, FDA Consent to GRN-47 June 2000 Environmental Issues: Non-Toxic, Readily Biodegradable And Safe.

The Effect Of Increasing Levels of Healthy Trac™. 1.5 Grams/Day Boosts The Immune System. 2.1 Grams/Serving (8.4 Grams/Day Total) Lowers LDL And Total Cholesterol. 2.8 Grams/Serving Provides 10% of The Daily Fiber Requirement. 4.0 Grams Per Day Lowers Serum Insulin And Blood Sugar Levels. Benefit For Diabetics. 5.6 Grams/Day Provides 20% of The Daily Requirement For Dietary Fiber.

Healthy Trac™ As A Prebiotic Fiber Food Source For Bifidus Bacteria. 65% Slowly Fermented to Short Chain Fatty Acids (SCFA) At Normal Flora Growth Rates. Butyrate Generation High (30% Of Total SCFA). Inhibits K88 E. coli Attachment To Gut Epithelial Cells. Reduces beta-glucuronidase activity. None Of The Side Effects OF Other Fibers.

Short Chain Fatty Acids (SCFA) With Health Trac™

University Of Minnesota Y2000 Clinical Study Results. Clinical Design Double Blind, Placebo Controlled 100 Human Subjects, 6 Months, Free Living Diet Effects Of Daily Dietary Supplementation On Blood Lipid, Gastrointestional And Immune Function.

Digestive Health Results 10 Fold Increase In Anaerobes. 100 Fold Increase In Bifidobacteria. 10 Fold Increase In Lactobacilli. 10 Fold Decrease In Enterobacters. 10 Fold Decrease In Clostridium No Adverse Reactions Or Negative Side Effects. Stool Consistency Softened. Regular Healthy Bowel Movements.

Blood Lipid And Serum Analyte Studies. 15 % Reduction In Total Cholesterol In Hyperlipidemic Subjects. 5-10% Reduction In Serum Glucose Levels % Reduction Of Serum Insulin Levels

Immune System Proliferation. Healthy Trac™ Immune Activity Is 3 Times More Active Than The Popular Herb Echinacea. Has Been Shown To Enhance Natural Killer Cell (NK) Activity. This Is Very Beneficial During The Ageing Process. Healthy Trac™ Naturally Stimulates The Immune System By Increasing Most Immune Cell Populations Including Monocytes And Dendritic Cells.

Immune System Benefits In-Vitro Human Testing. Healthy Trac™ Stimulates Macrophage Proliferation More Powerful Than Echinacea In Side-By- Side Testing

Stimulation of Human Natural Killer Cytotoxicity Against K562 Tumor Cells

In vitro Evaluation Of AG As An Adjunct to Cancer Therapy.  2 to 6 Times Greater NK Cell Cytotoxicity Against K562 Tumor Cells Through The Stimulation of Gamma Interferon Production.  Increased Production of Tumor Necrosis Factor (TNF) Alpha, Interleukin (IL) 1 And 6.  TNF Alpha is Also Toxic to Tumor Cells.  IL-1 And 6 Increase Vascular Permeability.

SWCRI Immune System Activation - Properdin Properdin is a Natural Activator of The Immune System’s Complement Pathway. Properdin is an Accurately Measurable Immune System Marker. Responsible For Non-specific Host Defense Mechanisms, Including Defense Against Cold And Flu. Overall Profound Immunostimulatory Effects.

Properdin Increase.

Human Clinical Research: No Adverse Reaction In Any Clinical Trial. Health East, 2001, 500 Children, 12 Weeks. University of Florida, 2000, 33 Subjects, 6 Weeks. University of Minnesota, 2000, 100 Subjects, 23 Weeks. SWC Research Institute, 1999, 48 Subjects, 4 Weeks. SWC Research Institute, 1999, 24 Subjects, 4 Weeks. University of Minnesota, 1998, 22 Subjects, 6 Weeks.

Scientific Evidence. Journal Papers And Clinical Studies